Incorporated is developing innovative biopharmaceutical products through its unique signaling pathway simulations. strives to use technology to better the human condition.

Computational Biology Solutions in Drug Design

Our company develops combination drugs for complex metabolic diseases, testing potential binary and ternary therapies in dynamic data-driven simulations at various combinations of two or three points in the pathways, and choosing to bring forward the most effective pair-wise combinations that show the lowest probability of side effects.

A similar dynamic, data driven simulation approach has now been demonstrated to be effective for a variety of purposes by the National Science Foundation (NSF) and Air Force Office of Scientific Research (AFOSR). Data driven simulation is being employed in preclinical and clinical studies.